MPNs | Clinical

The Expanding Role of Interferons in Myeloproliferative Neoplasms

November 24, 2021

In an interview with Targeted Oncology™, Richard T. Silver, MD, discussed the role of interferon in the treatment of myeloproliferative neoplasm as well as the importance of the 3-year global MPN initiative being conducted by the MPN Research Foundation.

Treating Post-MPN Acute Leukemia Remains an Unmet Medical Need

October 18, 2021

In an interview with Targeted Oncology, Gabriela Hobbs, MD discussed the current treatment landscape for MPNs and the research that is aiming to address post-MPN acute leukemia and unmet needs for the patient population.

Unmet Needs Loom for Later-Line Options in MPNs

October 13, 2021

Srdan Verstovsek, MD, PhD, a professor of Medicine and a hematologic oncologist at the University of Texas MD Anderson Cancer Center, discusses the need for new drugs after patients with myelofibrosis are treated with JAK inhibitors.